Crossmark Global Holdings, Inc. United Therapeutics Corp Transaction History
Crossmark Global Holdings, Inc.
- $5.22 Billion
- Q1 2024
A detailed history of Crossmark Global Holdings, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 3,629 shares of UTHR stock, worth $1.14 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,629
Previous 3,567
1.74%
Holding current value
$1.14 Million
Previous $784,000
6.25%
% of portfolio
0.02%
Previous 0.02%
Shares
28 transactions
Others Institutions Holding UTHR
# of Institutions
561Shares Held
43.1MCall Options Held
501KPut Options Held
529K-
Black Rock Inc. New York, NY5.57MShares$1.75 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.68MShares$1.47 Billion0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.41MShares$1.07 Billion0.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$899 Million7.91% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.15MShares$677 Million0.78% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $14.3B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...